Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -4.85% |
| 2023 | -61.75% |
| 2022 | 322.93% |
| 2021 | 6.85% |
| 2020 | 29.02% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2017 | 0.00% |